Ariadne Solutions applies artificial intelligence and natural language processing to bioanalytical data to accelerate data review and offer levels of sensitivity and granularity not possible before. The company was founded on the belief that the right tools paired with bioanalytical expertise can help biopharmaceutical scientists better identify and predict risk early in drug development, while accelerating drug development timelines and delivering treatments to the patients who need them most.